Table II.
Risk Group | All Unilateral Stratum C Patients (n=50) | |||
---|---|---|---|---|
High | Intermediate | Low | ||
N=7 | N=7 | N=36 | ||
Age at Study Enrollment (months) | ||||
Median (Range) | 24.4 (17.2-71.5) | 13.1 (6.1-28.6) | 29.4 (4.7-108.6) | 26.4 (4.7-108.6) |
Age at Diagnosis (categorical) | ||||
Birth - <12 months | 0 | 3 | 5 | 8 (16%) |
≥12 months - <60 months | 6 | 4 | 25 | 35 (70%) |
≥60 months | 1 | 0 | 6 | 7 (14%) |
Gender | ||||
Male | 3 | 4 | 18 | 25 (50%) |
Female | 4 | 3 | 18 | 25 (50%) |
Race | ||||
White | 4 | 5 | 17 | 26 (52%) |
Black | 2 | 2 | 13 | 17 (34%) |
Other | 1 | 0 | 6 | 7 (14%) |
Reese-Ellsworth Group | ||||
VA | 1 | 3 | 4 | 8 (16%) |
VB | 6 | 4 | 32 | 42 (84%) |
International Classification of Retinoblastoma | ||||
Group D | 0 | 3 | 19 | 22 (44%) |
Group E | 7 | 4 | 17 | 28 (56%) |